HARBIN, China--(BUSINESS WIRE)--Renhuang Pharmaceuticals, Inc. (or "the Company", Stock symbol: RHGP.OB), a leading provider of natural health care products in the People's Republic of China (PRC), today announced guidance for the three months ending October 31, 2006, which is the fourth quarter of the Company’s Chinese operating subsidiary fiscal year.
